Developer docs
API playgroundTry for free, no card

Search company profiles

ADDvise Group AB (publ)

Full company profile

uuid00spjcf

Namestring
ADDvise Group AB (publ)
Legal namestring
ADDvise Group AB (publ)
Websiteurl
addvisegroup.se
Company typeenum
Private
Founded yearstring
-
Descriptiontext

ADDvise Group AB (publ) is a Swedish life science conglomerate that develops, acquires, and supplies laboratory environments and medical technology products to healthcare and research institutions globally. Operating through two business areas — Lab (complete research environments, laboratory solutions, and cleanroom systems) and Sjukvård/Healthcare (medical technology products including surgical tables, medical cables, and diabetic care consumables) — the group manages over 20 subsidiary companies, each retaining local management autonomy while leveraging shared corporate support functions. The company is headquartered in Stockholm, Sweden, at Grev Turegatan 30, and historically traded on Nasdaq First North Premier Growth Market before being acquired by Amplex AB in February 2026 (with >99% ownership achieved), resulting in delisting and a transition to private ownership as a business area within the Amplex Group.

The group's revenue model is predominantly B2B enterprise sales of hardware (medical devices, laboratory equipment, cleanroom systems) with a recurring revenue element from diabetes consumables. Over 80% of revenue is generated in non-SEK currencies across markets in Europe, the Americas, and the Middle East, with operations in Sweden, the USA, and the UAE. Pricing is negotiated on a quote-based, multi-year contract basis with institutional customers including hospitals, laboratories, and research facilities. For FY2025, the company reported net sales of 1,605.7 MSEK and EBITA of 273.3 MSEK (17.0% margin), with a net debt/EBITDA ratio of 3.0x. The group follows a roll-up acquisition strategy supplemented by organic growth, with stated long-term targets of 15% annual EBITA growth and 15% ROCE.

Customer-facing delivery occurs through a decentralized network of subsidiaries (including Merit Cables, Surgical Tables Inc., and MRC Cleanroom Systems) that maintain direct sales relationships with healthcare and research institutions, while the parent company provides strategic direction, M&A capability, and corporate functions. In 2025, the company underwent significant balance sheet restructuring — a 457 MSEK rights issue in February 2025, 1,600 MSEK senior unsecured bond framework on Nasdaq Stockholm in May 2025, and a Nordea refinancing agreement reducing annual financial costs by ~56 MSEK — positioning the company for ongoing inorganic and organic growth under Amplex ownership.

Short descriptiontext

ADDvise Group AB (publ) is a Swedish life science conglomerate that supplies laboratory environments and medical technology products to healthcare and research institutions globally through over 20 decentralized subsidiaries in two business areas: Lab and Healthcare.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
laboratory solutions, medical technology products, cleanroom systems, research environment solutions, medical device distribution
Industry3 codes
1Lab Furniture, Facilities & Utilities (Benches, Casework, Gas/Water Systems)
CodeHLAGAIAMPrimaryYes
2Science & STEM Lab Equipment & Supplies (Chemistry, Biology, Physics, Makerspaces)
CodeEDAEAIACPrimaryNo
3Hospital Shared Services, GPOs & System Support Organizations
CodeHLAFAAAOPrimaryNo
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing33911
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code2 codes
  • Laboratory Apparatus & Furniture3821
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices & Laboratory Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Technology Products
TypeHardware Sales
Description

Development and delivery of medical technology products to healthcare units. Revenue generated through direct sales of medical devices and equipment.

addvisegroup.se
2Laboratory Solutions and Equipment
TypeHardware Sales
Description

Complete research environments and laboratory solutions sold to research institutions. Includes laboratory equipment, cleanroom systems, and related products.

addvisegroup.se
3Diabetes Products
TypeSubscription Recurring
Description

Consumable products within diabetes care segment, contributing to recurring revenue streams in the healthcare division

addvisegroup.se
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Enterprise/B2B pricing for healthcare and research institutions
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based and negotiated directly with institutional customers including hospitals, laboratories, and research facilities

addvisegroup.se
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ADDvise Group supplies complete laboratory solutions and medical technology products to healthcare and research units via two business areas: Lab (research environments, laboratory solutions, cleanroom systems) and Sjukvård/Healthcare (medical devices, surgical tables, medical cables, diabetes care consumables). Sales and delivery are executed through more than 20 decentralized subsidiary companies that maintain direct customer relationships with hospitals, research institutions, and laboratories globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • EBITA margin improvement to 17.0% in 2025 from 16.2% in 2024
+1 more record
Product overview1 text field

ADDvise Group AB is a diversified life science conglomerate operating through two main business segments: Lab and Healthcare (Sjukvård). The Lab segment delivers complete research environments and laboratory solutions, while the Healthcare segment develops and delivers medical technology products. The company operates through over 20 subsidiaries including Merit Cables, Surgical Tables Inc., and MRC Cleanroom Systems, providing products and services to healthcare and research units. The company uses a decentralized ownership model, developing and acquiring high-quality companies within these segments.

Product and service6 records
1Healthcare (Sjukvård) business area
CategoryMedical technology products
Description

Medical technology products developed and delivered to healthcare units — including surgical tables, medical-grade cables for patient-care devices, and consumables within diabetes care — through subsidiaries such as Surgical Tables Inc. and Merit Cables. Targeted at hospitals, healthcare units, and medical facilities.

2Lab business area
CategoryLaboratory and research environment solutions
Description

Complete research environments and laboratory solutions delivered to research units and laboratories, including cleanroom systems and specialized research equipment. Targeted at research institutions, academic facilities, and commercial laboratories.

3Surgical Tables (by Surgical Tables Inc.)
CategorySurgical tables and medical equipment
Description

Surgical tables and related medical equipment for healthcare facilities globally; produced by the wholly-owned ADDvise subsidiary Surgical Tables Inc. (STI).

4Medical-grade cables (by Merit Cables)
CategoryMedical device cables
Description

Cable products used in medical devices and patient care, manufactured globally by the wholly-owned ADDvise subsidiary Merit Cables for hospitals and medical device OEMs.

5Cleanroom systems (by MRC Cleanroom Systems)
CategoryCleanroom systems
Description

Cleanroom systems and solutions for controlled laboratory environments in healthcare and research facilities, delivered globally by the wholly-owned ADDvise subsidiary MRC Cleanroom Systems.

6Diabetes care consumables
CategoryDiabetes care consumables
Description

Recurring consumable products used in diabetes care, supplied within the Healthcare division; contributes to subscription-style recurring revenue for the group.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Öhrlings PricewaterhouseCoopers AB
Strategic tierCoreTypeOthers
Description

Johan Engstam from Öhrlings PricewaterhouseCoopers AB serves as the principal auditor for ADDvise Group since May 2023, providing audit services for financial statements and regulatory compliance.

addvisegroup.se
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hamilton manufactures laboratory automation, liquid handling robots, and workstations — directly overlapping with ADDvise's lab instruments offering for research and clinical customers.

TypeBroad incumbent
Description

Sartorius is a much larger established player in life science tools and bioprocessing equipment — overlapping with ADDvise's Lab segment through filtration, fluid management, and lab consumables.

TypeBroad incumbent
Description

Agilent supplies analytical laboratory instruments and consumables to research institutions globally; its workflows intersect with ADDvise's Lab customers but its product scope is significantly broader.

TypeDirect peer
Description

Getinge is a Swedish-headquartered peer operating in surgical/medical equipment and ICU/life science solutions; its Surgical Workplaces and Life Science divisions directly parallel ADDvise's Sjukvård and Lab businesses.

TypeEmerging player
Description

Eppendorf focuses on pipettes, lab consumables, and bioprocessing equipment for life science customers — adjacent to ADDvise's lab portfolio but more narrowly focused on liquid handling and consumables.

TypeBroad incumbent
Description

Bio-Rad supplies life science research and clinical diagnostics instrumentation — its lab equipment catalog and channel to research institutions broadly mirrors ADDvise's Lab customer base.

TypeBroad incumbent
Description

Mettler-Toledo supplies precision laboratory instruments (balances, pipettes, automated workstations) — a category that overlaps with ADDvise's laboratory equipment portfolio, though at a much broader scale.

TypeDirect peer
Description

Belimed supplies sterilization, disinfection, and laboratory cleaning equipment to hospitals and research institutions globally, with comparable selling motion into regulated healthcare end markets.

TypeDirect peer
Description

STERIS is a direct peer with overlapping exposure to sterilization, surgical tables (Steris HSG/STERIS Surgical Tables), and laboratory/cleanroom equipment sold to hospitals and research institutions — closely mirroring ADDvise's Sjukvård plus Lab segments.

TypeOthers
Description

Donaldson provides industrial filtration including cleanroom and life science filtration products — enabling/adjacent to ADDvise's cleanroom systems offering rather than competing head-to-head.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ADDvise Group AB (publ)

Medical Devices & Laboratory Equipmentaddvisegroup.se

ADDvise Group AB (publ) is a Swedish life science conglomerate that supplies laboratory environments and medical technology products to healthcare and research institutions globally through over 20 decentralized subsidiaries in two business areas: Lab and Healthcare.

What ADDvise Group AB (publ) does

ADDvise Group AB (publ) is a Swedish life science conglomerate that develops, acquires, and supplies laboratory environments and medical technology products to healthcare and research institutions globally. Operating through two business areas — Lab (complete research environments, laboratory solutions, and cleanroom systems) and Sjukvård/Healthcare (medical technology products including surgical tables, medical cables, and diabetic care consumables) — the group manages over 20 subsidiary companies, each retaining local management autonomy while leveraging shared corporate support functions. The company is headquartered in Stockholm, Sweden, at Grev Turegatan 30, and historically traded on Nasdaq First North Premier Growth Market before being acquired by Amplex AB in February 2026 (with >99% ownership achieved), resulting in delisting and a transition to private ownership as a business area within the Amplex Group.

The group's revenue model is predominantly B2B enterprise sales of hardware (medical devices, laboratory equipment, cleanroom systems) with a recurring revenue element from diabetes consumables. Over 80% of revenue is generated in non-SEK currencies across markets in Europe, the Americas, and the Middle East, with operations in Sweden, the USA, and the UAE. Pricing is negotiated on a quote-based, multi-year contract basis with institutional customers including hospitals, laboratories, and research facilities. For FY2025, the company reported net sales of 1,605.7 MSEK and EBITA of 273.3 MSEK (17.0% margin), with a net debt/EBITDA ratio of 3.0x. The group follows a roll-up acquisition strategy supplemented by organic growth, with stated long-term targets of 15% annual EBITA growth and 15% ROCE.

Customer-facing delivery occurs through a decentralized network of subsidiaries (including Merit Cables, Surgical Tables Inc., and MRC Cleanroom Systems) that maintain direct sales relationships with healthcare and research institutions, while the parent company provides strategic direction, M&A capability, and corporate functions. In 2025, the company underwent significant balance sheet restructuring — a 457 MSEK rights issue in February 2025, 1,600 MSEK senior unsecured bond framework on Nasdaq Stockholm in May 2025, and a Nordea refinancing agreement reducing annual financial costs by ~56 MSEK — positioning the company for ongoing inorganic and organic growth under Amplex ownership.

ADDvise Group AB (publ) firmographics

Firmographics
Name
ADDvise Group AB (publ)
Legal name
ADDvise Group AB (publ)
Website
https://addvisegroup.se
Company type
Private
Operating status
Operating
Short description
ADDvise Group AB (publ) is a Swedish life science conglomerate that supplies laboratory environments and medical technology products to healthcare and research institutions globally through over 20 decentralized subsidiaries in two business areas: Lab and Healthcare.
Ownership category
akta.pro rank

ADDvise Group AB (publ) industry classification

Industry
Product category
Medical Devices & Laboratory Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (33911), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Laboratory Apparatus & Furniture (3821), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Lab Furniture, Facilities & Utilities (Benches, Casework, Gas/Water Systems) (HLAGAIAM)
akta.pro secondary industries
Science & STEM Lab Equipment & Supplies (Chemistry, Biology, Physics, Makerspaces) (EDAEAIAC), Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO)

Keywords

  • Laboratory solutions
  • Medical technology products
  • Cleanroom systems
  • Research environment solutions
  • Medical device distribution

Where ADDvise Group AB (publ) is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

ADDvise Group AB (publ) business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

  1. Medical Technology Products: Development and delivery of medical technology products to healthcare units. Revenue generated through direct sales of medical devices and equipment.
  2. Laboratory Solutions and Equipment: Complete research environments and laboratory solutions sold to research institutions. Includes laboratory equipment, cleanroom systems, and related products.
  3. Diabetes Products: Consumable products within diabetes care segment, contributing to recurring revenue streams in the healthcare division

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/B2B pricing for healthcare and research institutions

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

ADDvise Group AB (publ) product offering

Product offering

Core offering

ADDvise Group supplies complete laboratory solutions and medical technology products to healthcare and research units via two business areas: Lab (research environments, laboratory solutions, cleanroom systems) and Sjukvård/Healthcare (medical devices, surgical tables, medical cables, diabetes care consumables). Sales and delivery are executed through more than 20 decentralized subsidiary companies that maintain direct customer relationships with hospitals, research institutions, and laboratories globally.

Product overview

ADDvise Group AB is a diversified life science conglomerate operating through two main business segments: Lab and Healthcare (Sjukvård). The Lab segment delivers complete research environments and laboratory solutions, while the Healthcare segment develops and delivers medical technology products. The company operates through over 20 subsidiaries including Merit Cables, Surgical Tables Inc., and MRC Cleanroom Systems, providing products and services to healthcare and research units. The company uses a decentralized ownership model, developing and acquiring high-quality companies within these segments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare (Sjukvård) business area Medical technology products developed and delivered to healthcare units — including surgical tables, medical-grade cables for patient-care devices, and consumables within diabetes care — through subsidiaries such as Surgical Tables Inc. and Merit Cables. Targeted at hospitals, healthcare units, and medical facilities.
  • Lab business area Complete research environments and laboratory solutions delivered to research units and laboratories, including cleanroom systems and specialized research equipment. Targeted at research institutions, academic facilities, and commercial laboratories.
  • Surgical Tables (by Surgical Tables Inc.) Surgical tables and related medical equipment for healthcare facilities globally; produced by the wholly-owned ADDvise subsidiary Surgical Tables Inc. (STI).
  • Medical-grade cables (by Merit Cables) Cable products used in medical devices and patient care, manufactured globally by the wholly-owned ADDvise subsidiary Merit Cables for hospitals and medical device OEMs.
  • Cleanroom systems (by MRC Cleanroom Systems) Cleanroom systems and solutions for controlled laboratory environments in healthcare and research facilities, delivered globally by the wholly-owned ADDvise subsidiary MRC Cleanroom Systems.
  • Diabetes care consumables Recurring consumable products used in diabetes care, supplied within the Healthcare division; contributes to subscription-style recurring revenue for the group.

Quantifiable outcome

  • EBITA margin improvement to 17.0% in 2025 from 16.2% in 2024
  • +1 more outcomes

Companies that use ADDvise Group AB (publ)

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

ADDvise Group AB (publ) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

ADDvise Group AB (publ) partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Öhrlings PricewaterhouseCoopers ABcoreOthersJohan Engstam from Öhrlings PricewaterhouseCoopers AB serves as the principal auditor for ADDvise Group since May 2023, providing audit services for financial statements and regulatory compliance.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

ADDvise Group AB (publ) competitors and assessment

Company assessment

Direct peers

  • Hamilton Company: Hamilton manufactures laboratory automation, liquid handling robots, and workstations — directly overlapping with ADDvise's lab instruments offering for research and clinical customers.
  • Getinge AB: Getinge is a Swedish-headquartered peer operating in surgical/medical equipment and ICU/life science solutions; its Surgical Workplaces and Life Science divisions directly parallel ADDvise's Sjukvård and Lab businesses.
  • Belimed AG: Belimed supplies sterilization, disinfection, and laboratory cleaning equipment to hospitals and research institutions globally, with comparable selling motion into regulated healthcare end markets.
  • STERIS plc: STERIS is a direct peer with overlapping exposure to sterilization, surgical tables (Steris HSG/STERIS Surgical Tables), and laboratory/cleanroom equipment sold to hospitals and research institutions — closely mirroring ADDvise's Sjukvård plus Lab segments.

Broad incumbents

  • Sartorius AG: Sartorius is a much larger established player in life science tools and bioprocessing equipment — overlapping with ADDvise's Lab segment through filtration, fluid management, and lab consumables.
  • Agilent Technologies: Agilent supplies analytical laboratory instruments and consumables to research institutions globally; its workflows intersect with ADDvise's Lab customers but its product scope is significantly broader.
  • Bio-Rad Laboratories: Bio-Rad supplies life science research and clinical diagnostics instrumentation — its lab equipment catalog and channel to research institutions broadly mirrors ADDvise's Lab customer base.
  • Mettler-Toledo International: Mettler-Toledo supplies precision laboratory instruments (balances, pipettes, automated workstations) — a category that overlaps with ADDvise's laboratory equipment portfolio, though at a much broader scale.

Emerging players

  • Eppendorf AG: Eppendorf focuses on pipettes, lab consumables, and bioprocessing equipment for life science customers — adjacent to ADDvise's lab portfolio but more narrowly focused on liquid handling and consumables.

Others

  • Donaldson Company, Inc. Donaldson provides industrial filtration including cleanroom and life science filtration products — enabling/adjacent to ADDvise's cleanroom systems offering rather than competing head-to-head.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ADDvise Group AB (publ) social profiles

Digital presence

ADDvise Group AB (publ) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ADDvise Group AB (publ) leadership team

Management profile

Number of profiles

Profiles4 records

ADDvise Group AB (publ) subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

ADDvise Group AB (publ) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ADDvise Group AB (publ) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADDvise Group AB (publ)

What does ADDvise Group AB (publ) do?

ADDvise Group supplies complete laboratory solutions and medical technology products to healthcare and research units via two business areas: Lab (research environments, laboratory solutions, cleanroom systems) and Sjukvård/Healthcare (medical devices, surgical tables, medical cables, diabetes care consumables). Sales and delivery are executed through more than 20 decentralized subsidiary companies that maintain direct customer relationships with hospitals, research institutions, and laboratories globally.

Is ADDvise Group AB (publ) a public or private company?

ADDvise Group AB (publ) is a private company. It is classified as corporate owned and is currently operating.

When was ADDvise Group AB (publ) founded?

ADDvise Group AB (publ) was founded in -1.

Where is ADDvise Group AB (publ) based?

ADDvise Group AB (publ) is headquartered in Stockholm, Sweden, in the Europe region.

How does ADDvise Group AB (publ) make money?

Three revenue lines are on record. Medical Technology Products are the primary driver. The others are laboratory Solutions and Equipment and diabetes Products.

Who are ADDvise Group AB (publ)'s main competitors?

Direct peers on record are Hamilton Company, Getinge AB, Belimed AG and STERIS plc. Broad incumbents are Sartorius AG, Agilent Technologies, Bio-Rad Laboratories and Mettler-Toledo International. Eppendorf AG is listed as an emerging player. Donaldson Company, Inc. is listed as an others.

Does ADDvise Group AB (publ) have an API?

No public API is recorded for ADDvise Group AB (publ).

What industry is ADDvise Group AB (publ) in?

ADDvise Group AB (publ)'s product category is Medical Devices & Laboratory Equipment. Its primary akta.pro industry code is HLAGAIAM, Lab Furniture, Facilities & Utilities (Benches, Casework, Gas/Water Systems), with a secondary code of EDAEAIAC, Science & STEM Lab Equipment & Supplies (Chemistry, Biology, Physics, Makerspaces). Its NAICS code is 339112 and its SIC code is 3821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
news.cision.comAmplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDviseAmplex AB has entered into additional agreements to acquire shares and warrants in ADDvise Group AB, increasing its ownership to approximately 56.65% of the share capital and 64.42% of the votes. These agreements are part of a broader offer strategy announced in December 2025, which aims to acquire full control of ADDvise.news.cision.comAmplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)Amplex AB has increased its cash offer for ADDvise Group AB, raising the consideration to 1.72 SEK per A and B share (from 1.65 SEK) and to 0.52 SEK per warrant (from 0.49 SEK), effective December 19, 2025. The bidder has also secured conditional share purchase agreements with five significant ADDvise shareholders controlling approximately 21.11% of share capital, bringing total committed shares to around 51.49% of capital and 60.57% of votes. The revised offer strengthens Amplex's position ahead of the takeover, which remains subject to Swedish takeover rules and customary conditions.news.cision.comAmplex AB announces a cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)Swedish Amplex AB announced a public cash offer to acquire all remaining shares and warrants in ADDvise Group AB (publ) for SEK 1.65 per share and SEK 0.49 per warrant, valuing the target at approximately SEK 1.05 billion. The offer represents a positive premium of approximately 41.51 percent for class B shares compared to the December 9, 2025 closing price, with an acceptance period running from December 11, 2025 to January 23, 2026. Amplex, which already holds approximately 29.79 percent of share capital and 43.58 percent of votes in ADDvise, cited challenges including unstable demand and limited financial flexibility as rationale for taking the company private.news.cision.comLinklaters has advised Amplex AB on its public cash offer for ADDvise Group AB (publ)Linklaters advised Amplex AB on its public cash offer for ADDvise Group AB, which is valued at over SEK 1 billion. The offer includes all of ADDvise's four listed instruments and the company has a revenue close to SEK 1.7 billion. The transaction involves financing arrangements and targets a group developing and acquiring life sciences companies.news.cision.comAmplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ)Amplex AB announced on 10 December 2025 a public cash offer to acquire all shares and warrants in ADDvise Group AB (publ), with the offer document published the same day. The acceptance period runs from 11 December 2025 to 23 January 2026, and if the offer is declared unconditional by 27 January 2026, settlement is expected around 30 January 2026. Nordea Bank Abp serves as financial advisor and Linklaters Advokatbyrå Aktiebolag as legal advisor to Amplex in connection with the offer.news.cision.comADDvise announces preliminary outcome of the rights issueADDvise Group AB announced the preliminary outcome of its rights issue, with approximately 78.4% of shares subscribed and an oversubscription rate of about 183%. The rights issue will raise around SEK 457 million for the company. The final outcome is expected to be disclosed on April 8, 2025.news.cision.comDeparting CEO of ADDvise divests shares of series A to a major shareholder of ADDviseADDvise Group AB announced that departing CEO Rikard Akhtarzand has agreed to divest 2,500,000 Series A shares to major shareholder Kenneth Lindqvist for a total value of SEK 37.5 million. The transaction is currently pending regulatory approval from the Swedish Inspectorate of Strategic Products before it can be finalized.news.cision.comADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq StockholmADDvise Group AB has published a listing prospectus approved by the Swedish Financial Supervisory Authority to apply for admission of its senior secured bonds to trading on Nasdaq Stockholm. The company initially issued SEK 1,000 million in bonds in May 2023 under a SEK 2,000 million framework, with trading expected to commence around June 28, 2023.news.cision.comADDvise issues senior secured bondsADDvise Group AB successfully placed SEK 1,000 million in senior secured bonds with a three-year tenor, driven by strong demand from institutional investors. The company intends to use the proceeds to fully redeem its outstanding existing bond loan at a premium of 103.625 percent. Pareto Securities AB and Skandinaviska Enskilda Banken AB acted as coordinators for this financing transaction.GlobeNewswireADDvise converts loan of 5 MSEK to B-sharesADDvise Group issued 2,813,187 B-shares to Mangold at 1.82 SEK per share, raising about 5.1 MSEK. The issue repays debt, dilutes capital by 9.0% and votes by 2.8%, and increases total shares to 31,245,834.